Literature DB >> 18458861

Cerebrotendinous xanthomatosis: neuropathological findings.

B Pilo de la Fuente1, I Ruiz, A Lopez de Munain, A Jimenez-Escrig.   

Abstract

Cerebrotendinous xanthomatosis is an inherited autosomal recessive lipid storage disease caused by a 27-hydroxylase enzyme deficiency, characterised clinically by tendon xanthomas, premature cataracts, chronic diarrhoea and progressive neurologic dysfunction. The disease is very uncommon and there are very few pathological descriptions. We report a 52-year-old male who presented with a neuropsychiatric disorder and cognitive decline. Despite treatment the patient developed optic atrophy, parkinsonism and dementia and died. The autopsy revealed a nonspecific brain and cerebellar atrophy. Under microscopic examination, lipid crystal clefts, neuronal loss, demyelination, reactive astrocytosis and perivascular macrophages were found. These findings suggest the limited reversibility of the disease, and its poor prognosis, specially if treatment is not started early.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458861     DOI: 10.1007/s00415-008-0729-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  [Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases].

Authors:  J Campdelacreu; E Muñoz; A Cervera; S Jaumà; M Girós; E Tolosa
Journal:  Neurologia       Date:  2002-12       Impact factor: 3.109

2.  Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis.

Authors:  A Verrips; L H Hoefsloot; G C Steenbergen; J P Theelen; R A Wevers; F J Gabreëls; B G van Engelen; L P van den Heuvel
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

3.  Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27).

Authors:  S Sugama; A Kimura; W Chen; S Kubota; Y Seyama; N Taira; Y Eto
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

4.  Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings.

Authors:  F Barkhof; A Verrips; P Wesseling; M S van Der Knaap; B G van Engelen; F J Gabreëls; A Keyser; R A Wevers; J Valk
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

Review 5.  Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.

Authors:  Mohammed H Moghadasian; Gerald Salen; Jiri J Frohlich; Charles H Scudamore
Journal:  Arch Neurol       Date:  2002-04

Review 6.  Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis.

Authors:  A Verrips; B G van Engelen; R A Wevers; B M van Geel; J R Cruysberg; L P van den Heuvel; A Keyser; F J Gabreëls
Journal:  Arch Neurol       Date:  2000-04

7.  Cerebrotendinous xanthomatosis diagnosed after traumatic subdural haematoma.

Authors:  J Arpa; C Sánchez; A Vega; A Cruz-Martínez; T Ferrer; R López-Pajares; J Muñoz; P Barreiro
Journal:  Rev Neurol       Date:  1995 May-Jun       Impact factor: 0.870

Review 8.  Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.

Authors:  Mohammed H Moghadasian
Journal:  Clin Invest Med       Date:  2004-02       Impact factor: 0.825

9.  Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.

Authors:  E Leitersdorf; A Reshef; V Meiner; R Levitzki; S P Schwartz; E J Dann; N Berkman; J J Cali; L Klapholz; V M Berginer
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature.

Authors:  D Soffer; D Benharroch; V Berginer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more
  11 in total

1.  A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis.

Authors:  Andrea Mignarri; Gian Nicola Gallus; Maria Teresa Dotti; Antonio Federico
Journal:  J Inherit Metab Dis       Date:  2014-01-18       Impact factor: 4.982

Review 2.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

3.  Nationwide survey on cerebrotendinous xanthomatosis in Japan.

Authors:  Yoshiki Sekijima; Shingo Koyama; Tsuneaki Yoshinaga; Masayoshi Koinuma; Yuji Inaba
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

4.  The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression.

Authors:  Andrea Mignarri; Maria Teresa Dotti; Antonio Federico; Nicola De Stefano; Marco Battaglini; Irene Grazzini; Paolo Galluzzi; Lucia Monti
Journal:  J Neurol       Date:  2017-03-21       Impact factor: 4.849

5.  MR spectroscopy detects lipid peaks in cerebrotendinous xanthomatosis.

Authors:  E K Embiruçu; M C G Otaduy; A K Taneja; C C Leite; Fernando Kok; L T Lucato
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

Review 6.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

Review 7.  Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).

Authors:  Gerald Salen; Robert D Steiner
Journal:  J Inherit Metab Dis       Date:  2017-10-04       Impact factor: 4.982

Review 8.  Psychiatric manifestations in cerebrotendinous xanthomatosis.

Authors:  M J Fraidakis
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

Review 9.  Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.

Authors:  Shuke Nie; Guiqin Chen; Xuebing Cao; Yunjian Zhang
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

10.  Isoform-specific Inhibition of N-methyl-D-aspartate Receptors by Bile Salts.

Authors:  Angela Koch; Michele Bonus; Holger Gohlke; Nikolaj Klöcker
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.